SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-033905
Filing Date
2024-08-01
Accepted
2024-08-01 09:05:00
Documents
66
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vcel-20240630.htm   iXBRL 10-Q 1062819
2 EX-10.1 ex101fourthamendmenttothed.htm EX-10.1 14264
3 EX-10.2 ex102tenthamendmenttothedi.htm EX-10.2 10987
4 EX-31.1 ex311ceocertificationq22024.htm EX-31.1 13487
5 EX-31.2 ex312cfocertificationq22024.htm EX-31.2 11564
6 EX-32.1 ex321ceoandcfosoxcertifica.htm EX-32.1 9383
  Complete submission text file 0001628280-24-033905.txt   5791897

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcel-20240630.xsd EX-101.SCH 33287
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vcel-20240630_cal.xml EX-101.CAL 61918
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vcel-20240630_def.xml EX-101.DEF 154202
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcel-20240630_lab.xml EX-101.LAB 522805
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcel-20240630_pre.xml EX-101.PRE 339586
69 EXTRACTED XBRL INSTANCE DOCUMENT vcel-20240630_htm.xml XML 834807
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

IRS No.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35280 | Film No.: 241164646
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)